The Food-effect on Alectinib Pharmacokinetics
The Food-effect of a Standardized Dutch Breakfast on the Pharmacokinetics of Oral Alectinib (Alecensa®) Using a Stable Isotopically Labelled Microtracer Approach
Sponsor: The Netherlands Cancer Institute
Listed as NCT05710133, this NA trial focuses on NSCLC and remains completed. Sponsored by The Netherlands Cancer Institute, it has been updated 7 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Jul 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Enrolling By Invitation NA
-
Mar 2024 — Jul 2024 [monthly]
Enrolling By Invitation NA
▶ Show 2 earlier versions
-
Feb 2024 — Mar 2024 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Mar 2023 — Feb 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The Netherlands Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .